|
Q3 2018
Filed on Nov 14, 2018
|
59,716
|
$24.3 - $29.7
$1.45M - $1.77M
|
|
Oncomed Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
209,088
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
297,559
|
$2.6 - $3.95
$774K - $1.18M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
136,507
|
N/A
|
|
Adamas Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
82,912
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
109,496
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
207,641
|
$25.03 - $28.93
$5.2M - $6.01M
|
|
Esterline Technologies Corp
|
Q3 2018
Filed on Nov 14, 2018
|
50,408
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
66,714
|
$8.02 - $10.04
$535K - $670K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
40,210
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
12,164
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
664,917
|
$2.6 - $3.59
$1.73M - $2.39M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
37,203
|
$33.9 - $47.77
$1.26M - $1.78M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
55,971
|
$101.0 - $127.7
$5.65M - $7.15M
|
|
Portola Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
13,564
|
N/A
|
|
Foamix Pharmaceuticals LTD
|
Q3 2018
Filed on Nov 14, 2018
|
217,670
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
21,429
|
$194.22 - $240.03
$4.16M - $5.14M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
106,593
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
16,209
|
$88.86 - $117.49
$1.44M - $1.9M
|
|
Aspen Insurance Holdings LTD
|
Q3 2018
Filed on Nov 14, 2018
|
50,405
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
488,243
|
$2.81 - $3.78
$1.37M - $1.85M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
11,744
|
$29.37 - $49.48
$345K - $581K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
199,340
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
31,162
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
18,187
|
$108.88 - $128.82
$1.98M - $2.34M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
63,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
162,781
|
$20.96 - $28.2
$3.41M - $4.59M
|
|
Alexion Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
41,179
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
114,073
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
91,662
|
$9.54 - $13.87
$874K - $1.27M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
393,476
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
21,450
|
$42.88 - $53.7
$920K - $1.15M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
70,601
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
73,871
|
$136.72 - $160.01
$10.1M - $11.8M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
43,586
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
26,285
|
$72.59 - $97.27
$1.91M - $2.56M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
13,884
|
$55.53 - $65.87
$771K - $915K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
434,335
|
$20.56 - $23.18
$8.93M - $10.1M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
308,582
|
$21.39 - $23.09
$6.6M - $7.13M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
75,099
|
$10.49 - $12.87
$788K - $967K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
45,000
|
$24.51 - $39.46
$1.1M - $1.78M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
31,248
|
$88.49 - $127.55
$2.77M - $3.99M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
150,911
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
38,008
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
70,000
|
$39.9 - $42.61
$2.79M - $2.98M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
17,500
|
$84.05 - $94.46
$1.47M - $1.65M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
19,251
|
$18.36 - $27.29
$353K - $525K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
14,956
|
$144.42 - $162.65
$2.16M - $2.43M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
63,125
|
$10.32 - $13.06
$651K - $824K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
25,000
|
$59.22 - $71.99
$1.48M - $1.8M
|
|